Related Experiment Video
Updated: Dec 14, 2025
Utero-tubal Embryo Transfer and Vasectomy in the Mouse Model
Published on: February 28, 2014
Pediatric kidney transplantation in the United States
Kambiz Etesami1,2, Rachel Lestz1, Rachel Hogen1,2
1Children's Hospital Los Angeles.
Insights
Pediatric kidney transplantation is a successful treatment, but requires unique approaches. Improving access to size-matched organs and standardizing care can enhance long-term outcomes for young patients.
Area of Science:
- Pediatric Nephrology
- Transplant Surgery
- Immunology
Background:
- Pediatric kidney transplantation has advanced significantly, offering a vital treatment for end-stage renal disease in children.
- It necessitates distinct considerations compared to adult transplantation due to unique patient and donor factors.
Purpose of the Study:
- To review the current state and future directions of pediatric kidney transplantation.
- To highlight the unique challenges and opportunities in this field.
Main Methods:
- Review of recent advancements in surgical techniques and immunosuppression protocols.
- Analysis of donor-recipient pairing strategies and organ allocation.
Main Results:
- Despite progress, prolonged wait times persist for pediatric patients, impacting access to appropriately sized organs.
- Optimization of immunosuppression has led to allograft survival measured in decades.
- Adult kidneys are increasingly utilized for pediatric recipients, including infants and small-for-age children.
Conclusions:
- Enhanced access to size-matched organs is crucial to reduce wait times and improve long-term prognosis for pediatric recipients.
- Standardization of surgical and perioperative management through longitudinal multicenter studies is needed.
- Continued advances in immunosuppression promise improved patient and graft survival with minimized adverse effects.
Purpose Of Review:
Pediatric kidney transplantation has made great strides over the preceding years. It has become an accepted and successful remedy for thousands of patients worldwide. For best outcomes, it must be viewed and treated as a distinct entity from adult transplantation with focus on the unique challenges particular to its cohort.
Recent Findings:
Although efforts have been made to decrease geographic disparity and increase allograft access throughout, an unintended consequence has been prolonged wait times for pediatric patients. Concurrently, ideally size-matched organs from older pediatric donors are also being bypassed. Nevertheless, advances in surgical technique and a better understanding of the limits of donor-recipient pairing have facilitated continued usage of adult kidneys for both infants and small for age children. Immunosuppression optimization has meant mean allograft survival measured in decades.
Summary:
Enhanced access is needed to better size-matched organs for pediatric recipients, helping diminish wait times for the youngest patients, and improving their long-term prognosis. Longitudinal multicenter studies are needed to help standardize protocols, especially as it relates to optimal surgical and perioperative management. Advances in immunosuppression will continue to enhance patient and graft survival while minimizing adverse effects.
